Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Participants With Muscular Dystrophy
Clinical trial NCT02239224 · COMPLETED
Trial details
- NCT number
- NCT02239224
- Sponsor
- aTyr Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-04
- Primary completion
- 2015-12-14
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.